EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical use of progesterone in human sperm preparation media for increasing IVF success

Nicole O McPherson, Mark Nottle, Stephan McIlfatrick, Anmol Saini, Hamish Hamilton, Emily Bowman, Cathryn A Tully, Leanne Pacella-Ince, Deirdre Zander-Fox, Hassan W Bakos

Reproductive BioMedicine Online · 2024

DOI: 10.1016/j.rbmo.2023.103625 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2024. Verfasst von Nicole O McPherson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Reproduction and Development, School of Biomedicine, University of Adelaide, Adelaide, Australia; Freemasons Centre for Male Health and…. Hauptthemen laut MEDLINE: Progesterone, Infertility. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: Can the addition of progesterone and neurotensin, molecular agents found in the female reproductive tract, after sperm washing increase the fertilization potential of human spermatozoa? DESIGN: (i) Cohort study of 24 men. Spermatozoa selected by swim-up were incubated in either progesterone or neurotensin (0.1-100 µM) for 1-4 h, and hyperactive motility and binding to hyaluronan (0.1-100 µM) were assessed. The effect of progesterone 10 µM on sperm function was assessed in a blinded manner, including: hyperactive motility, binding to hyaluronan, tyrosine phosphorylation, acrosome reaction and oxidative DNA damage. (i) Embryo safety testing [one-cell mouse embryo assay (MEA), endotoxin and sterility counts (n = 3)] in preclinical embryo models of IVF (murine and porcine, n = 7 each model) and a small preliminary human study (n = 4) of couples undergoing standard IVF with oocytes inseminated with spermatozoa ± 10 µM progesterone. RESULTS: Progesterone 10 µM increased sperm binding to hyaluronan, hyperactive motility and tyrosine phosphorylation (all P 0.05). Progesterone 10 µM in human embryo culture media passed embryo safety testing (MEA, endotoxin concentration and sterility plate count). In preclinical models of IVF, the exposure of spermatozoa to progesterone 10 µM and oocytes to progesterone 1 µM was not detrimental, and increased the fertilization rate in mice and the blastocyst cell number in mice and pigs (all P ≤ 0.03). In humans, every transferred blastocyst that had been produced from spermatozoa exposed to progesterone resulted in a live birth. CONCLUSION: The addition of progesterone to sperm preparation media shows promise as an adjunct to current methods for increasing fertilization potential. Randomized controlled trials are required to determine the clinical utility of progesterone for improving IVF outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProgesteroneInfertilityHumansMaleFemaleAnimalsMiceSwineFertilization in VitroNeurotensinHyaluronic AcidCohort StudiesSemenSpermatozoaTyrosineEndotoxins

Stichwörter der Autor:innen

Assisted reproductive technologyCapacitationCulture mediaEmbryogenesisInfertility

Substanzen

ProgesteroneNeurotensinHyaluronic AcidTyrosineEndotoxins

Autor:innen und Institutionen

  • Discipline of Reproduction and Development, School of Biomedicine, University of Adelaide, Adelaide, Australia; Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, Australia; Robinson Rese…
  • Discipline of Reproduction and Development, School of Biomedicine, University of Adelaide, Adelaide, Australia; Robinson Research Institute, University of Adelaide, Adelaide, Australia.
  • Monash IVF Group, Clayton, Australia.
  • Discipline of Reproduction and Development, School of Biomedicine, University of Adelaide, Adelaide, Australia; Robinson Research Institute, University of Adelaide, Adelaide, Australia; Repromed, Dulwich, Australia.
  • Discipline of Reproduction and Development, School of Biomedicine, University of Adelaide, Adelaide, Australia; Monash IVF Group, Clayton, Australia; Monash University, Clayton, Australia.
  • Monash IVF Group, Clayton, Australia; University of Newcastle, Newcastle, Australia; Memphasys Ltd, Homebush, Australia.

Förderung

  • Australian Research Council

Zitieren

APA

McPherson, N. O., Nottle, M., McIlfatrick, S., Saini, A., Hamilton, H., Bowman, E., Tully, C. A., Pacella-Ince, L., Zander-Fox, D., & Bakos, H. W. (2024). Clinical use of progesterone in human sperm preparation media for increasing IVF success. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2023.103625

Vancouver

McPherson NO, Nottle M, McIlfatrick S, Saini A, Hamilton H, Bowman E, et al. Clinical use of progesterone in human sperm preparation media for increasing IVF success. Reproductive BioMedicine Online. 2024. doi:10.1016/j.rbmo.2023.103625

BibTeX
@article{McPherson2024,
  author = {McPherson, Nicole O and Nottle, Mark and McIlfatrick, Stephan and Saini, Anmol and Hamilton, Hamish and Bowman, Emily and Tully, Cathryn A and Pacella-Ince, Leanne and Zander-Fox, Deirdre and Bakos, Hassan W},
  title = {Clinical use of progesterone in human sperm preparation media for increasing IVF success},
  journal = {Reproductive BioMedicine Online},
  year = {2024},
  doi = {10.1016/j.rbmo.2023.103625}
}
Kostenlos starten →